The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BUZZ-U.S. Stocks on the Move-Ciena, Matrix, Methode, Mitek

Thu, 04th Sep 2014 14:59

(For faster updates on individual market-movers, Eikon usersplease use search string "STXBZ US"; for more market insights,including options activity, ; for the Day Aheadnewsletter, http://link.reuters.com/mex49s; for the Morning NewsCall newsletter, http://link.reuters.com/nex49s)

U.S. stocks opened slightly higher on Thursday, after theEuropean Central Bank cut interest rates to record lows and aflurry of economic data indicated the U.S. economy was steadilyimproving. The Dow Jones industrial average was up 0.37percent at 17,141.74, the S&P 500 was up 0.47 percent at2,010.16 and the Nasdaq Composite was up 0.2 percent4,581.71.

** AMAZON.COM INC, $347.65, +2.55 pct

Sanford C. Bernstein raised its price target on the stock ofthe online retailer to $450 from $360. "Amazon has built abetter, more cost-effective retail model than the vast majorityof brick-and-mortar retailers," Bernstein analysts said in anote. The median price target on stock is $400, according toThomson Reuters data.

** AEROVIRONMENT INC, $32, -4.90 pct

The drone maker reported a first-quarter loss of 16 centsper share, wider than the average analysts' estimate of 11cents, according to Thomson Reuters I/B/E/S

** NORDSTROM INC, $70.66, +1.46 pct

The apparel retailer authorized a $1 billion sharerepurchase. The latest buyback excludes $323 million remainingunder earlier plan.

** TASER INTERNATIONAL INC, $17.95, +7.23 pct

The stun gun maker received multiple orders from theCleveland police department for its Taser brand smart weapons.The company did not disclose the financial terms.

The stock had gained about 35 percent since Aug. 8, a daybefore fatal shooting in Ferguson, Missouri, through Wednesday.

** METHODE ELECTRONICS INC, $39.58, +15.53 pct

The electronic component maker said it expects full-yearprofit of $2.10-$2.20 per share on revenue of $870 million-$885million, up from prior forecast of a profit of $1.85-$2 pershare on revenue of $835 million-$860 million. MethodeElectronics reported a better-than-expected first quarterresults, helped by higher sales and better margins in itsautomotive unit.

The company's shares rose 16.5 percent to a 14-year-high of$40.

** IRONWOOD PHARMACEUTICALS INC, $12.39, -4.62 pct

Cowen & Co lowered its rating on the drugmaker's stock to"market perform" from "outperform", citing recent physicianfeedback on Ironwood's constipation drug, Linzess. The brokeragealso slashed its price target to $10.50 from $16.00, saying itsconsultants believe adoption of Linzess by general practitionerswill be slow.

** NORTHSTAR REALTY FINANCE CORP, $18.35, -2.65 pct

The real estate investment trust priced its offering of 45million shares at $18.40 per share, a discount of 2.4 percent tostock's Wednesday close. The offering represents 22.7 percent ofoutstanding shares as of Aug. 8.

The stock is most traded on New York Stock Exchange onThursday. Deutsche Bank Securities Inc will borrow and sell 22.5million shares to underwriters in the offering.

** SHOE CARNIVAL INC, $19.64, -11.37 pct

The footwear retailer reported lower-than-expected secondquarter sales and profit as fewer customers visited its storesand expenses rose. Its profit has now missed estimates for thelast three quarters. The company forecast third quartercomparable-store sales to either decline up to 1 percent or growup to 1 percent.

Susquehanna Financial Group analysts cut price target to $24from $25 on the stock which had fallen 24 percent this year upto Wednesday's close.

** SOLARCITY CORP, $70.8244, +4.58 pct

The solar panel installer said it would open 20 newoperations centers in seven U.S. states. The company, backed byTesla Motors Inc founder Elon Musk, says new centersexpected to create more than 600 additional jobs.

** BAZAARVOICE INC, $7.9808, +6.41 pct

B. Riley & Co raises price target on stock of the softwaremaker to $10 from $9.75, saying net new client additions in Q1were significantly higher than it had estimated.

Bazaarvoice, which provides businesses online and socialmedia tools to interact with customers, reportedhigher-than-expected Q1 revenue and smaller-than-expected losson Wednesday

** VERIFONE SYSTEMS INC, $35.93, +4.02 pct

The credit card swipe machine maker raised full-year revenueforecast for the third time, encouraged by strong sales ofdevices that can accept chip-embedded credit cards. VeriFonealso raised full-year profit forecast and reportedbetter-than-expected third quarter revenue.

The company is benefiting as U.S. retailers upgrade theirpoint-of-sale terminals to systems compatible with more securecredit cards in the wake of several data breaches. Up toWednesday's close, the stock had risen nearly 30 percent thisyear.

** ARLINGTON ASSET INVESTMENT CORP, $27.197, -4.20pct

The mortgage investor said it was offering 2.75 millionshares of Class A common stock - 14 percent of its totaloutstanding shares - at $27.61 each, a 2.7 pct discount toWednesday's close.

Arlington said it plans to use the proceeds to acquireassets. Up to Wednesday's close, the stock had risen 7.6 percentthis year.

** STEREOTAXIS INC,$3.35, +17.54 pct

The medical device maker received U.S. FDA's marketingapproval for its device used during procedures to assess heartactivity. The device, called Vdrive Robotic Navigation System,is designed to remotely control catheter during such procedures.

** KAMADA LTD, $5.75, -19.69 pct

The Israel-based drugmaker's experimental drug to treat aninherited condition that raises the risk of lung and liverdisease failed in a mid-stage study. The drug, Inhaled Alpha-1Antitrypsin, did not show a statistically significantdifference, compared with a placebo. Glassia, an intravenousversion of the drug, is already being marketed by Baxter Inc in the United States.

** CIENA CORP, $18.76, -8.31 pct

The network equipment forecast fourth quarter revenue of$570 million-$610 million, below the average analyst estimate of$628.9 million. The company said it expects fourth quarteradjusted gross margin in the high 30s to low 40s percent range.

** MITEK SYSTEMS INC, $3.55, +49.79 pct

The mobile imaging software maker agreed on Wednesday tosettle all pending litigation with financial services group USAAover five of its patents relating to image capture on mobiledevices. Mitek's lawsuit filed in 2012 also included allegationsof misappropriation of trade secrets, breach of contract andfraud. The company said neither party will make any payment oradmit liability on any claims.

** GOPRO INC, $54.4, -4.33 pct

J.P. Morgan cut its rating on the stock of the maker of camera makers to "neutral" from "overweight", saying the stockis trading above its price target of $51. The median pricetarget on stock is $46.50. Of nine analysts covering the stock,2 have "buy" ratings and 7 have "hold" or equivalent ratings. Upto Wednesday's close, the stock had risen 137 percent since itsdebut on June 26.

** MEMORIAL PRODUCTION PARTNERS LP, $22.42, -3.20pct

The oil and gas producer said it would offer 13 millioncommon units; representing 18 percent of outstanding shares asof Wednesday. The company said it plans to use net proceeds fromthe underwritten public offering to pay down debt.

** MATTRESS FIRM HOLDING CORP, $63.41, +11.62 pct

The company said it would buy privately held beddingretailer The Sleep Train Inc for $425 million, its sixth andlargest acquisition announced in the past year, to expand itspresence on the West Coast.

** NEWLINK GENETICS CORP, $26.79, +3.16 pct

NewLink Genetics said the U.S. Food and Drug Administrationallowed the company to start testing an experimental Ebolavaccine in humans.

The move follows a decision to begin initial human testingof a GlaxoSmithKline vaccine this month and an approvalto fast track tests of a Johnson & Johnson vaccine.

** TIBCO SOFTWARE INC, $21.9101, +4.14 pct

The business software maker said it was reviewing itsstrategic and financial alternatives as part of a processinitiated by its board on Aug. 16 to maximize shareholder value. The company has formed a special committee of independentdirectors to undertake the review.

** MATRIX SERVICE CO, $22.7, -22.07 pct

The engineering and construction services provider's fourthquarter revenue and profit missed analysts' estimates due to a47 percent rise in costs. Revenue from the company's oil, gasand chemical segment, which provides construction andmaintenance services to North American oil producers, fell about22 percent to $52.1 million. Matrix also forecast full-yearearnings below estimates.

** PVH CORP, $128.12, +9.38 pct

The apparel company's second quarter profit beatexpectations, helped by strong sales of its TommyHilfiger-branded clothes. PVH cut its full-year revenue forecastto $8.4 billion from $8.5 billion, but it reaffirmed its profitforecast. (Compiled by Rohit T.K. in Bangalore; Editing by Joyjeet Das)

More News
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.